These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 30647096)
21. Increased sympathovagal imbalance evaluated by heart rate variability is associated with decreased T2* MRI and left ventricular function in transfusion-dependent thalassemia patients. Pattanakuhar S; Phrommintikul A; Tantiworawit A; Konginn S; Srichairattanakool S; Chattipakorn SC; Chattipakorn N Biosci Rep; 2018 Feb; 38(1):. PubMed ID: 29330222 [TBL] [Abstract][Full Text] [Related]
22. Development of thalassaemic iron overload cardiomyopathy despite low liver iron levels and meticulous compliance to desferrioxamine. Anderson LJ; Westwood MA; Prescott E; Walker JM; Pennell DJ; Wonke B Acta Haematol; 2006; 115(1-2):106-8. PubMed ID: 16424659 [TBL] [Abstract][Full Text] [Related]
23. [T inversion in Friedreich's ataxia]. Ruser HR; Ruser I Z Kardiol; 1976 Sep; 65(9):795-9. PubMed ID: 969828 [TBL] [Abstract][Full Text] [Related]
24. Cardiomyopathy in Friedreich's Ataxia. Salazar P; Indorkar R; Dietrich M; Farzaneh-Far A Eur Heart J; 2018 Feb; 39(7):631. PubMed ID: 29059291 [No Abstract] [Full Text] [Related]
25. Assessment of iron overload with T2* magnetic resonance imaging. Anderson LJ Prog Cardiovasc Dis; 2011; 54(3):287-94. PubMed ID: 22014495 [TBL] [Abstract][Full Text] [Related]
26. [Association of myocardiopathy and spino-cerebellar degeneration (Friedreich's disease) Apropos of a case]. Gabriel B; Pinsard N; Gérard R; Louchet E Pediatrie; 1974 Jun; 29(4):367-77. PubMed ID: 4438039 [No Abstract] [Full Text] [Related]
27. Myocardial iron clearance during reversal of siderotic cardiomyopathy with intravenous desferrioxamine: a prospective study using T2* cardiovascular magnetic resonance. Anderson LJ; Westwood MA; Holden S; Davis B; Prescott E; Wonke B; Porter JB; Walker JM; Pennell DJ Br J Haematol; 2004 Nov; 127(3):348-55. PubMed ID: 15491298 [TBL] [Abstract][Full Text] [Related]
28. [Two case studies of hypertrophic cardiomyopathy in Friedreich's ataxia]. Cervantes-Arriaga A; Rodríguez-Violante M; Villar-Velarde A; Vargas-Cañas S Gac Med Mex; 2009; 145(4):343-6. PubMed ID: 20073435 [TBL] [Abstract][Full Text] [Related]
29. Distribution of cardiac iron measured by magnetic resonance imaging (MRI)-R*2. Yamamura J; Grosse R; Graessner J; Janka GE; Adam G; Fischer R J Magn Reson Imaging; 2010 Nov; 32(5):1104-9. PubMed ID: 21031515 [TBL] [Abstract][Full Text] [Related]
30. Advanced iron-overload cardiomyopathy in a genetic murine model is rescued by resveratrol therapy. Das SK; Zhabyeyev P; Basu R; Patel VB; Dyck JRB; Kassiri Z; Oudit GY Biosci Rep; 2018 Feb; 38(1):. PubMed ID: 29208771 [TBL] [Abstract][Full Text] [Related]
31. Prooxidant mechanisms in iron overload cardiomyopathy. Cheng CF; Lian WS Biomed Res Int; 2013; 2013():740573. PubMed ID: 24350287 [TBL] [Abstract][Full Text] [Related]
32. Hypotensive anesthesia for a patient with Friedreich's ataxia and cardiomyopathy. Bird TM; Strunin L Anesthesiology; 1984 Apr; 60(4):377-80. PubMed ID: 6703395 [No Abstract] [Full Text] [Related]
38. Idebenone in patients with Friedreich ataxia. Schöls L; Vorgerd M; Schillings M; Skipka G; Zange J Neurosci Lett; 2001 Jun; 306(3):169-72. PubMed ID: 11406322 [TBL] [Abstract][Full Text] [Related]
39. Cardiac energetics are abnormal in Friedreich ataxia patients in the absence of cardiac dysfunction and hypertrophy: an in vivo 31P magnetic resonance spectroscopy study. Lodi R; Rajagopalan B; Blamire AM; Cooper JM; Davies CH; Bradley JL; Styles P; Schapira AH Cardiovasc Res; 2001 Oct; 52(1):111-9. PubMed ID: 11557239 [TBL] [Abstract][Full Text] [Related]
40. Decreasing effects of iron toxicosis on selenium and glutathione peroxidase activity. Bartfay WJ; Bartfay E West J Nurs Res; 2002 Mar; 24(2):119-31. PubMed ID: 11858344 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]